ATE291437T1 - Verwendung von botulinustoxin zur gewinnung eines produkts für die verwendung bei gelenkerkrankungen, insbesondere hüftgelenkarthrose, epicondylitis und rotatorkappenerkrankungen - Google Patents
Verwendung von botulinustoxin zur gewinnung eines produkts für die verwendung bei gelenkerkrankungen, insbesondere hüftgelenkarthrose, epicondylitis und rotatorkappenerkrankungenInfo
- Publication number
- ATE291437T1 ATE291437T1 AT02727002T AT02727002T ATE291437T1 AT E291437 T1 ATE291437 T1 AT E291437T1 AT 02727002 T AT02727002 T AT 02727002T AT 02727002 T AT02727002 T AT 02727002T AT E291437 T1 ATE291437 T1 AT E291437T1
- Authority
- AT
- Austria
- Prior art keywords
- epicondylitis
- disease
- product
- joint diseases
- botulinus toxin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
- A61K38/4893—Botulinum neurotoxin (3.4.24.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/108331—Preservative, buffer, anticoagulant or diluent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2001UD000002A ITUD20010002A1 (it) | 2001-01-05 | 2001-01-05 | Uso della tossina botulinica per la soluzione di patologie articolari, in particolare della coxartrosi, della epicondilite e della patolo |
PCT/IB2002/000003 WO2002053175A2 (en) | 2001-01-05 | 2002-01-04 | Use of botulinum toxin for treatment of articular pathologies |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE291437T1 true ATE291437T1 (de) | 2005-04-15 |
Family
ID=11460457
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02727002T ATE291437T1 (de) | 2001-01-05 | 2002-01-04 | Verwendung von botulinustoxin zur gewinnung eines produkts für die verwendung bei gelenkerkrankungen, insbesondere hüftgelenkarthrose, epicondylitis und rotatorkappenerkrankungen |
Country Status (15)
Country | Link |
---|---|
US (2) | US7208166B2 (de) |
EP (1) | EP1357937B1 (de) |
JP (1) | JP2004517114A (de) |
CN (1) | CN1318089C (de) |
AT (1) | ATE291437T1 (de) |
AU (1) | AU2002222432B8 (de) |
CA (1) | CA2433765C (de) |
CY (1) | CY1105490T1 (de) |
DE (1) | DE60203370T2 (de) |
DK (1) | DK1357937T3 (de) |
ES (1) | ES2242858T3 (de) |
IT (1) | ITUD20010002A1 (de) |
PT (1) | PT1357937E (de) |
RU (1) | RU2283664C2 (de) |
WO (1) | WO2002053175A2 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003009897A (ja) * | 2001-07-03 | 2003-01-14 | Keiji Oguma | ボツリヌス毒素の分離・精製法 |
US7691394B2 (en) * | 2002-05-28 | 2010-04-06 | Botulinum Toxin Research Associates, Inc. | High-potency botulinum toxin formulations |
KR20050094817A (ko) * | 2002-12-20 | 2005-09-28 | 보툴리늄 톡신 리서치 어쏘시에이츠, 인크. | 개선된 약제학적 보툴리늄 독소 조성물 |
CN101065743A (zh) * | 2004-08-03 | 2007-10-31 | 威格沃克公司 | 涉及累进投注的游戏方法和装置 |
US8323666B2 (en) * | 2005-08-01 | 2012-12-04 | Allergan, Inc. | Botulinum toxin compositions |
EP2364168A1 (de) | 2008-12-04 | 2011-09-14 | Botulinum Toxin Research Associates, Inc. | Verlängerte botulinustoxin-formulierung zur anwendung bei menschen oder säugetieren |
US9393291B2 (en) | 2012-04-12 | 2016-07-19 | Botulinum Toxin Research Associates, Inc. | Use of botulinum toxin for the treatment of cerebrovascular disease, renovascular and retinovascular circulatory beds |
RU2496150C1 (ru) * | 2012-04-16 | 2013-10-20 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Омский государственный университет им. Ф.М. Достоевского" | Способ моделирования костной кристаллизации при коксартрозе in vitro |
US9492513B2 (en) * | 2013-04-25 | 2016-11-15 | Allergan, Inc. | Methods for treatment of hip and groin pain associated with femoroacetabular impingement (FAI) |
US9901627B2 (en) | 2014-07-18 | 2018-02-27 | Revance Therapeutics, Inc. | Topical ocular preparation of botulinum toxin for use in ocular surface disease |
US11484580B2 (en) | 2014-07-18 | 2022-11-01 | Revance Therapeutics, Inc. | Topical ocular preparation of botulinum toxin for use in ocular surface disease |
CN105567739B (zh) * | 2016-02-04 | 2019-07-12 | 郑州可尔利尔生物科技有限公司 | 病毒载体颗粒及其构建方法和应用 |
IL265109B2 (en) | 2016-09-13 | 2024-05-01 | Allergan Inc | Stabilized Clostridium toxin preparations without protein |
GB201815844D0 (en) * | 2018-09-28 | 2018-11-14 | Ipsen Biopharm Ltd | Therapeutic & comestic uses of botulinum neurotoxin serotype e |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9120306D0 (en) | 1991-09-24 | 1991-11-06 | Graham Herbert K | Method and compositions for the treatment of cerebral palsy |
EP1147775B1 (de) | 1993-12-28 | 2009-03-04 | Allergan, Inc. | Verwendung von Botulinumtoxin Typ B zur Herstellung eines Medikaments zur Reduzierung von Schmerzen bedingt durch Muskelkrankheit |
US6974578B1 (en) | 1993-12-28 | 2005-12-13 | Allergan, Inc. | Method for treating secretions and glands using botulinum toxin |
US5721215A (en) * | 1996-03-20 | 1998-02-24 | Allergan | Injectable therapy for control of muscle spasms and pain related to muscle spasms |
US6063768A (en) * | 1997-09-04 | 2000-05-16 | First; Eric R. | Application of botulinum toxin to the management of neurogenic inflammatory disorders |
TW574036B (en) | 1998-09-11 | 2004-02-01 | Elan Pharm Inc | Stable liquid compositions of botulinum toxin |
US6464986B1 (en) | 2000-04-14 | 2002-10-15 | Allegan Sales, Inc. | Method for treating pain by peripheral administration of a neurotoxin |
US6423319B1 (en) * | 2000-10-04 | 2002-07-23 | Allergan Sales, Inc. | Methods for treating muscle injuries |
-
2001
- 2001-01-05 IT IT2001UD000002A patent/ITUD20010002A1/it unknown
-
2002
- 2002-01-04 CN CNB028045831A patent/CN1318089C/zh not_active Expired - Fee Related
- 2002-01-04 PT PT02727002T patent/PT1357937E/pt unknown
- 2002-01-04 AT AT02727002T patent/ATE291437T1/de not_active IP Right Cessation
- 2002-01-04 CA CA002433765A patent/CA2433765C/en not_active Expired - Fee Related
- 2002-01-04 EP EP02727002A patent/EP1357937B1/de not_active Revoked
- 2002-01-04 JP JP2002554124A patent/JP2004517114A/ja active Pending
- 2002-01-04 DK DK02727002T patent/DK1357937T3/da active
- 2002-01-04 WO PCT/IB2002/000003 patent/WO2002053175A2/en active IP Right Grant
- 2002-01-04 ES ES02727002T patent/ES2242858T3/es not_active Expired - Lifetime
- 2002-01-04 RU RU2003124186/15A patent/RU2283664C2/ru not_active IP Right Cessation
- 2002-01-04 US US10/250,486 patent/US7208166B2/en not_active Expired - Lifetime
- 2002-01-04 AU AU2002222432A patent/AU2002222432B8/en not_active Withdrawn - After Issue
- 2002-01-04 DE DE60203370T patent/DE60203370T2/de not_active Revoked
-
2005
- 2005-06-23 CY CY20051100757T patent/CY1105490T1/el unknown
-
2006
- 2006-09-27 US US11/527,510 patent/US20070020294A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002053175A3 (en) | 2002-09-12 |
CN1491115A (zh) | 2004-04-21 |
US20070020294A1 (en) | 2007-01-25 |
CA2433765C (en) | 2008-10-28 |
EP1357937A2 (de) | 2003-11-05 |
AU2002222432B8 (en) | 2006-04-27 |
WO2002053175A2 (en) | 2002-07-11 |
DE60203370T2 (de) | 2006-02-09 |
PT1357937E (pt) | 2005-08-31 |
JP2004517114A (ja) | 2004-06-10 |
AU2002222432B2 (en) | 2006-04-13 |
ES2242858T3 (es) | 2005-11-16 |
DE60203370D1 (de) | 2005-04-28 |
RU2283664C2 (ru) | 2006-09-20 |
US20040071735A1 (en) | 2004-04-15 |
CN1318089C (zh) | 2007-05-30 |
DK1357937T3 (da) | 2005-08-01 |
CY1105490T1 (el) | 2010-04-28 |
ITUD20010002A1 (it) | 2002-07-05 |
RU2003124186A (ru) | 2005-01-10 |
US7208166B2 (en) | 2007-04-24 |
EP1357937B1 (de) | 2005-03-23 |
CA2433765A1 (en) | 2002-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE291437T1 (de) | Verwendung von botulinustoxin zur gewinnung eines produkts für die verwendung bei gelenkerkrankungen, insbesondere hüftgelenkarthrose, epicondylitis und rotatorkappenerkrankungen | |
ATE404587T1 (de) | Verfahren zur identifizierung von induktoren und inhibitoren proteolytischer antikörper, zusammensetzungen sowie deren verwendungen | |
IL132293A0 (en) | Use of lactoferin in the treatment of allergen induced disorders | |
MXPA03005273A (es) | Anticuerpos producidos procarioticamente y sus usos. | |
RS49828B (sr) | Farmaceutski sastavi | |
ATE364393T1 (de) | Verwendung eines botulinumtoxins zur herstellung eines arzneimittels zur peripheren behandlung von schmerzen, die nicht mit muskelspasmen oder kopfschmerzen in verbindung stehen | |
BR0112676A (pt) | Bifenilcarboxamidas | |
ES2163034T3 (es) | Composiciones micelares de copolimeros de bloque de polieter, para la objetivizacion de agentes biologicos como diana. | |
BRPI0313792B8 (pt) | utilização de proteína de eritropoetina, método para tratamento de distúrbios de distribuição de ferro em diabetes e medicamento para o seu tratamento | |
PT1016740E (pt) | Fibra precursora baseada em acrilonitrilo para fibras de carbono, processo para a sua producao, e sua utilizacao na formacao de uma fibra de carbono | |
SI1404304T1 (sl) | Tableta, obsegajoča cetirizin in psevdoefedrin | |
WO2004081229A3 (en) | Use of bv8 and/or eg-vegf to promote hematopoiesis | |
MY129643A (en) | Tablet comprising cetirizine and pseudoephedrine | |
PL365776A1 (en) | Method and line for the continuous stretching of hides and other similar products | |
ATE414100T1 (de) | Zielgerichtete ligande gegen peyer's flecke- und/oder m-zellen | |
DE69620755D1 (de) | Myrteextrakt enthaltendes haarpflegemittel, verfahren zur herstellung und verwendung insbesondere für eine antischuppenbehandlung | |
WO1998031712A3 (en) | Chitosan-conjugates with acidic chelate-complex forming agents | |
BR0307341A (pt) | Delta1-pirrolinas | |
DE59808193D1 (de) | Neue vitamin d-derivate mit cyclopropylringen in den seitenketten, verfahren und zwischenprodukte zu ihrer herstellung sowie ihre verwendung zur herstellung von arzneimitteln | |
WO2002004521A3 (en) | Proteins with integrin-like activity | |
MXPA03008406A (es) | Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos y agentes antagonistas de endotelina. | |
FR2873698B1 (fr) | Nouveau peptide et composition pharmaceutique le contenant | |
AU307051S (en) | Spray bottle | |
NZ514691A (en) | Method to type prion proteins | |
ATE309371T1 (de) | Protein mit dnase-aktivität |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1357937 Country of ref document: EP |
|
EEIH | Change in the person of patent owner | ||
RZN | Patent revoked |